40
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Enhancement of radiation-induced mitotic catastrophe by moderate hyperthermia

Pages 273-280 | Published online: 03 Jul 2009
 

Abstract

Purpose : To determine if a maximally radiosensitizing but non-toxic moderate hyperthermia treatment enhances radiation-induced mitotic catastrophe. Materials and methods : HeLa S3 cells were given a non-lethal heat treatment (41.5°C, 4h) and irradiated with 5Gy X-irradiation. Alterations in cell-cycle distribution, intracellular cyclin B1 levels, and the yield of mitotic catastrophe were then measured and compared to heat-only and radiation-only groups, as a function of time following treatment. Results : A greater accumulation of cells in S and G2 phases of the first cell-cycle post-treatment was observed in the combined heat and radiation groups, when compared with that observed following treatment with heat or radiation alone. Similarly, intracellular levels of cyclin B1 and the incidence of mitotic catastrophe were found to be greater in the combined treatment groups. Conclusions : This study provides further evidence that delays late in the cell cycle are implicated in increases in intracellular cyclin B1 levels and the subsequent development of mitotic catastrophe. Further, these data suggest a role for mitotic catastrophe occurring as a result of G2/M checkpoint abrogation in the process of thermal radiosensitization.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.